Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide)

Many patients pay $0 through manufacturer patient assistance programs. Contact our pharmacists — we handle all the paperwork.

Biktarvy is a complete, single-tablet HIV-1 treatment for adults and pediatric patients weighing at least 14 kg. It combines three antiretroviral medicines — bictegravir, emtricitabine, and tenofovir alafenamide — in one pill taken once daily with or without food.

Biktarvy has a high barrier to resistance and is recommended as a preferred first-line regimen by major HIV treatment guidelines. Our pharmacists provide individualized counseling and refill management.

• Once-daily, single-tablet regimen
• No food restriction
• High barrier to resistance
• Financial assistance programs available